A RESEARCH STUDY TO TEST HOW MULTIPLE DOSES OF FILGRASTIM HOSPIRA WORKS IN THE BODY OF HEALTHY STUDY SUBJECTS WHEN GIVEN BY SUBCUTANEOUS INJECTION (SC) (SHOT) COMPARED TO AN ALREADY U.S.-APPROVED DRUG NEUPOGEN® (AMGEN):